April 04, 2021
1 min read

Association of Community Cancer Centers announces executive committee members, trustees

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Association of Community Cancer Centers announced the newly elected members of its executive committee and board of trustees for the 2021-2022 term.

These individuals will help shape the association’s education and advocacy efforts.

David R. Penberthy, MD, MBA, radiation oncologist at Virginia Radiation Oncology Associates Inc., will serve as president-elect of the executive committee. Penberthy has practiced at Virginia Radiation Oncology Associates since 2002. He served as the association’s treasurer for the past 2 years.

Nadine J. Barrett, PhD, MA, MS, director of the Office of Health Equity and Disparities at Duke Cancer Institute, will serve as treasurer of the executive committee. Barrett, a medical sociologist and assistant professor in the department of community and family medicine at Duke University’s School of Medicine, previously served on the association’s board of trustees.

Olalekan Ajayi, PharmD, MBA, director of practice transformation at Sheridan Memorial Hospital, will continue to serve as secretary for another term. Randall A. Oyer, MD, the association’s immediate past president, also will serve on the executive committee.

Krista Nelson, MSW, LCSW, OSW-C, FAOSW, announced in early March as the new president of Association of Community Cancer Centers (ACCC), will lead the executive committee. Nelson is program manager of compassion and senior social worker at Providence Cancer Institute at Providence Health and Services in Oregon.

Krista Nelson, MSW, LCSW, OSW-C, FAOSW
Krista Nelson

“The experience and talent across many disciplines that is represented on this executive committee is not only impressive, but it truly represents the mission of ACCC,” Nelson said in a press release. “Those perspectives will be invaluable as this group guides ACCC and its members to share solutions and generate innovative resources for the oncology community as we move forward.”

Five individuals have been appointed to the association’s board of trustees.

They are: Robert Buras, MD, breast surgeon at Anne Arundel Medical Center; Amy Ellis, chief quality officer at Northwest Medical Specialties, PLLC; Pablo Gutman, MD, MBA, medical director at Holy Cross Hospital Cancer Institute; Ginah Nightingale, PharmD, BCOP, associate professor in the department of pharmacy practice at Sidney Kimmel Cancer Center at Thomas Jefferson University Health System; and David Spigel, MD, chief scientific officer at Sarah Cannon and partner at Tennessee Oncology.